FDA’s Drug Safety Office Reorganizing To Accommodate Influx Of PDUFA Staff

FDA's Office of Surveillance and Epidemiology is again undergoing changes as the agency continues to strengthen its drug safety operations. OSE is reorganizing prior to increasing staff by 50 percent to undertake new regulatory authorities